213 related articles for article (PubMed ID: 33800912)
1. Excess TGF-β1 Drives Cardiac Mesenchymal Stromal Cells to a Pro-Fibrotic Commitment in Arrhythmogenic Cardiomyopathy.
Maione AS; Stadiotti I; Pilato CA; Perrucci GL; Saverio V; Catto V; Vettor G; Casella M; Guarino A; Polvani G; Pompilio G; Sommariva E
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800912
[TBL] [Abstract][Full Text] [Related]
2. Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy.
Sommariva E; Brambilla S; Carbucicchio C; Gambini E; Meraviglia V; Dello Russo A; Farina FM; Casella M; Catto V; Pontone G; Chiesa M; Stadiotti I; Cogliati E; Paolin A; Ouali Alami N; Preziuso C; d'Amati G; Colombo GI; Rossini A; Capogrossi MC; Tondo C; Pompilio G
Eur Heart J; 2016 Jun; 37(23):1835-46. PubMed ID: 26590176
[TBL] [Abstract][Full Text] [Related]
3. Cyclophilin A in Arrhythmogenic Cardiomyopathy Cardiac Remodeling.
Rurali E; Pilato CA; Perrucci GL; Scopece A; Stadiotti I; Moschetta D; Casella M; Cogliati E; Sommariva E; Pompilio G; Nigro P
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096574
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway.
Xu R; Wu M; Wang Y; Li C; Zeng L; Wang Y; Xiao M; Chen X; Geng S; Lai P; Du X; Weng J
Mol Med; 2023 Apr; 29(1):59. PubMed ID: 37098464
[TBL] [Abstract][Full Text] [Related]
5. Ca
Maione AS; Faris P; Iengo L; Catto V; Bisonni L; Lodola F; Negri S; Casella M; Guarino A; Polvani G; Cerrone M; Tondo C; Pompilio G; Sommariva E; Moccia F
J Transl Med; 2022 Nov; 20(1):522. PubMed ID: 36371290
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.
Stadiotti I; Catto V; Casella M; Tondo C; Pompilio G; Sommariva E
J Cardiovasc Transl Res; 2017 Dec; 10(5-6):446-454. PubMed ID: 28983804
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell-derived exosomes improve diabetes mellitus-induced myocardial injury and fibrosis via inhibition of TGF-β1/Smad2 signaling pathway.
Lin Y; Zhang F; Lian XF; Peng WQ; Yin CY
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):123-126. PubMed ID: 31880529
[TBL] [Abstract][Full Text] [Related]
8. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts.
Cucoranu I; Clempus R; Dikalova A; Phelan PJ; Ariyan S; Dikalov S; Sorescu D
Circ Res; 2005 Oct; 97(9):900-7. PubMed ID: 16179589
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta1 from endometriomas promotes fibrosis in surrounding ovarian tissues via Smad2/3 signaling.
Shi LB; Zhou F; Zhu HY; Huang D; Jin XY; Li C; Dai Y; Pan YB; Zhang SY
Biol Reprod; 2017 Jan; 97(6):873-882. PubMed ID: 29136085
[TBL] [Abstract][Full Text] [Related]
10. Micro-vesicles from mesenchymal stem cells over-expressing miR-34a inhibit transforming growth factor-β1-induced epithelial-mesenchymal transition in renal tubular epithelial cells in vitro.
He J; Jiang YL; Wang Y; Tian XJ; Sun SR
Chin Med J (Engl); 2020 Apr; 133(7):800-807. PubMed ID: 32149762
[TBL] [Abstract][Full Text] [Related]
11. TGF-β
Salvarani N; Maguy A; De Simone SA; Miragoli M; Jousset F; Rohr S
Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004567. PubMed ID: 28500173
[TBL] [Abstract][Full Text] [Related]
12. Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy.
Rouhi L; Cheedipudi SM; Chen SN; Fan S; Lombardi R; Chen X; Coarfa C; Robertson MJ; Gurha P; Marian AJ
Cardiovasc Res; 2021 Sep; 117(11):2377-2394. PubMed ID: 33070193
[TBL] [Abstract][Full Text] [Related]
13. Epicardial differentiation drives fibro-fatty remodeling in arrhythmogenic cardiomyopathy.
Kohela A; van Kampen SJ; Moens T; Wehrens M; Molenaar B; Boogerd CJ; Monshouwer-Kloots J; Perini I; Goumans MJ; Smits AM; van Tintelen JP; van Rooij E
Sci Transl Med; 2021 Sep; 13(612):eabf2750. PubMed ID: 34550725
[TBL] [Abstract][Full Text] [Related]
14. ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.
Marriott S; Baskir RS; Gaskill C; Menon S; Carrier EJ; Williams J; Talati M; Helm K; Alford CE; Kropski JA; Loyd J; Wheeler L; Johnson J; Austin E; Nozik-Grayck E; Meyrick B; West JD; Klemm DJ; Majka SM
Am J Physiol Cell Physiol; 2014 Oct; 307(8):C684-98. PubMed ID: 25122876
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin reduces TGF-β1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: Role of protein phosphatase activation.
Rizvi F; Siddiqui R; DeFranco A; Homar P; Emelyanova L; Holmuhamedov E; Ross G; Tajik AJ; Jahangir A
Int J Cardiol; 2018 Nov; 270():228-236. PubMed ID: 30220377
[TBL] [Abstract][Full Text] [Related]
16. Activation of PPARα Ameliorates Cardiac Fibrosis in Dsg2-Deficient Arrhythmogenic Cardiomyopathy.
Qiu Z; Zhao Y; Tao T; Guo W; Liu R; Huang J; Xu G
Cells; 2022 Oct; 11(20):. PubMed ID: 36291052
[TBL] [Abstract][Full Text] [Related]
17. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
18. Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway.
Wu XP; Wang HJ; Wang YL; Shen HR; Tan YZ
Exp Cell Res; 2018 Jan; 362(1):17-27. PubMed ID: 28987540
[TBL] [Abstract][Full Text] [Related]
19. Endometriotic mesenchymal stem cells significantly promote fibrogenesis in ovarian endometrioma through the Wnt/β-catenin pathway by paracrine production of TGF-β1 and Wnt1.
Li J; Dai Y; Zhu H; Jiang Y; Zhang S
Hum Reprod; 2016 Jun; 31(6):1224-35. PubMed ID: 27005891
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
